Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 87 out of 100. Prevention and risk

Reviewed as evidence on: MIND / healthy dietary pattern and arterial health / cognition 2 studies (what the news said). Being listed means the study bears on the question, not that it agrees with the news.

Topic: Risk, prevention and care in population studies

Plain-language summary

Background Findings from observational studies suggest that dietary patterns may offer protective benefits against cognitive decline, but data from clinical trials are limited. The Mediterranean-DASH Intervention for Neurodegenerative Delay, known as the MIND diet, is a hybrid of the Mediterranean diet and the DASH (Dietary Approaches to Stop Hypertension) diet, with modifications to include foods that have been putatively associated with a decreased risk of dementia. Methods We performed a two-site, randomized, controlled trial involving older adults without cognitive impairment but with a family history of dementia, a body-mass index (the weight in kilograms divided by the square of the height in meters) greater than 25, and a suboptimal diet, as determined by means of a 14-item questionnaire, to test the cognitive effects of the MIND diet with mild caloric restriction as compared with a control diet with mild caloric restriction. Results A total of 1929 persons underwent screening, and 604 were enrolled; 301 were assigned to the MIND-diet group and 303 to the control-diet group. Conclusions Among cognitively unimpaired participants with a family history of dementia, changes in cognition and brain MRI outcomes from baseline to year 3 did not differ significantly between those who followed the MIND diet and those who followed the control diet with mild caloric restriction.

What this study adds

Evidence grade: Null result

The record lists 604 participants. In this randomized trial, people without cognitive impairment who followed the MIND diet showed no significant difference in cognition or brain MRI results after three years compared with those on a control diet. Reported effect size: Global cognition mean difference 0.035 standardised units (95% CI -0.022 to 0.092; P=0.23).

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Barnes, L. L., Dhana, K., Liu, X., Carey, V. J., Ventrelle, J., Johnson, K., et al. (2023). Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons. New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2302368

Vancouver

Barnes LL, Dhana K, Liu X, Carey VJ, Ventrelle J, Johnson K, et al. Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons. New England Journal of Medicine. 2023. doi:10.1056/NEJMoa2302368. PMID: 37466280.

BibTeX

@article{barnes2023-37466280,
  author  = {Barnes, L. L. and Dhana, K. and Liu, X. and Carey, V. J. and Ventrelle, J. and Johnson, K. and others},
  title   = {{Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons}},
  journal = {New England Journal of Medicine},
  year    = {2023},
  doi     = {10.1056/NEJMoa2302368},
  pmid    = {37466280},
  url     = {https://doi.org/10.1056/NEJMoa2302368}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

In this randomized trial, people without cognitive impairment who followed the MIND diet showed no significant difference in cognition or brain MRI results after three years compared with those on a control diet. It does not support the MIND diet as a way to prevent cognitive decline.

Study details

Limitations

Both arms received dietary counselling and weight-loss support, so the comparison is MIND versus a healthy control diet rather than versus usual eating; cognitively unimpaired participants over 3 years may be too short a window for dementia outcomes.

How this study scored 87/100
How this study's score is builtJournal tier 10 of 10; Journal's citation record 4 of 4; Study design 11 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 3 of 5; Sample size 2 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomized / blinded 1 of 2; Times cited 6 of 7; Citations per year 5 of 5; Impact for its field and year 6 of 6; Cited by studies here 3 of 6; Still being cited 4 of 4; Senior author's track record 4 of 4; Institution's track record 3 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read left out, no data. 85 of the 98 points it could be judged on, which is 87 of 100. Total 87 of 100.85 of the 98 points we could judge = 87 of 100

Published in a top-tier journal, and it is a randomized controlled trial. We have no data on free to read, so that was left out: it earned 85 of the 98 points we could judge it on, which is 87 out of 100.

ComponentPointsWhy
Journal tier 10 / 10 Tier 1 — top-tier general journal (New England Journal of Medicine)
Journal's citation record 4 / 4 New England Journal of Medicine: journal h-index 1,505 (OpenAlex, 2026-10-29)
Study design 11 / 12 A randomized controlled trial
Strength of evidence 3 / 5 Rated “null-result” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 3 / 5 2023 — within 6 year(s) of the newest study here
Sample size 2 / 4 604 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 1 / 2 Randomized (as stated in the record)
Times cited 6 / 7 Cited 357 times (OpenAlex, 2026-10-10)
Citations per year 5 / 5 71.4 citations a year over 5 year(s) since 2023
Impact for its field and year 6 / 6 Cited 83.3× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 3 / 6 Cited by 22 other studies in this library
Still being cited 4 / 4 Cited 339 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 4 / 4 Last-listed author Frank M. Sacks: h-index 126 (OpenAlex, whole career)
Institution's track record 3 / 3 Harvard University: institution h-index 3,235 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 5 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 37466280)
Free to read — / 2 Access not recorded — left out of this score
Points 85 / 98 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 85 of the 98 points we could judge it on is 87 out of 100.
Total 87 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

22 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.

Related studies in Prevention and risk from nearby years

Studies sharing this one's topic tags

Similar studies

More on Prevention and risk

See all studies in Prevention and risk →